Trading Members of the Exchange are hereby informed that effective from Monday, June 5, 2023, the Equity Shares of Hemant Surgical Industries Limited shall be listed and admitted to dealings on the Exchange in the list of 'MT' Group of Securities.Further in terms of SEBI circular No. CIR/MRD/DP/02/2012 dated January 20, 2012; the scrip will be in Trade-for-Trade segment for 10 trading days.
Name of the company
|
Hemant Surgical Industries Limited
|
Registered Office:
|
502, 5th Floor, Ecstacy Business Park, CoOp Society Limited, J.S.D. Road, Mulund (West), Mumbai – 400 080, India
Tel :022-25915289
Email: cs@hemantsurgical.com
Website: www.hemantsurgical.com
|
No. of Securities
|
1,04,40,000 Equity Shares of Rs.10/- each fully paid up
|
Distinctive Number range
|
1 To 10440000
|
Scrip ID on BOLT System
|
HSIL
|
Abbreviated Name on BOLT System
|
HSIL
|
Scrip Code
|
543916
|
ISIN No.
|
INE0GYI01028
|
Market Lot
|
1600
|
Issue Price for the current public issue
|
Rs. 90/- per share (Face Value of Rs. 10/- and premium of Rs. 80/-)
|
Date of Allotment in the public issue:
|
May 31, 2023
|
Pari Pasu
|
Yes
|
Financial Year
|
Mar-31
|
Lock in detail
|
As per Annexure I
|
Shareholding Pattern
|
As per Annexure II
|
a) Trading Members may note that as per the guidelines issued by SEBI dated 16th February 2000, securities of the company will only be traded in Dematerialised form. Trades effected in this scrip will be in minimum market lot (i.e.,1600equity shares) and the same shall be modified by the Exchange from time to time by giving prior market notice of at least one month.
b) Further the trading members may please note that the above-mentioned scrip will be a part of Special Pre-open Session (SPOS) on Monday, June 5, 2023. For further information on SPOS, the trading members are requested to refer to the Exchanges notice no. 20120216-29 dated February 16, 2012, on Enabling Special Pre-open Session for IPOs & Relisted Scrips.
c) The company has informed the Exchange that in respect of shares in demat form, necessary corporate action has been executed to have the lock-in period marked in the depository’s records
d) The Market Maker to the issue as mentioned in the prospectus is given below:
Hem Finlease Private Limited
Address: 203, Jaipur Tower, M I Road, Jaipur, Rajasthan 302001, India
Tel No: 0141-4051000
E-mail: ib@hemsecurities.com
Website: www.hemsecurities.com
Contact Person: Mr. Ashok Soni
SEBI Registration No: INZ000167734
Market Maker Registration No: SMEMM0674109092020
|
e) The Registrar to the issue as mentioned in the prospectus is given below
Bigshare Services Private Limited
Address: S6-2, 6th Floor, Pinnacle Business Park,
Next to Ahura Centre, Mahakali Caves Road,
Andheri (East) Mumbai – 400093, India.
Tel No.: +91 22 6263 8200
Facsimile: +91 22 6263 8299
Email: ipo@bigshareonline.com
Contact Person: Mr. Vinayak Morbale
Website: www.bigshareonline.com
SEBI Registration Number: MB/INR000001385
|
f) In case members require any clarifications on the subject matter of this notice, they may please contact any of the following:
a) At the company:
Mrs. Meenal Ajmera
Company Secretary & Compliance Officer
|
Address:
502, 5th Floor, Ecstacy Business Park, CoOp Society Limited, J.S.D. Road, Mulund (West), Mumbai – 400 080, India
Tel :022-25915289
Email: cs@hemantsurgical.com
Website: www.hemantsurgical.com
|
b) At the Exchange:
Mr. Raghavendra Bhat
Associate Manager
|
Tel.: (91) 022 2272 8915
|
Rupal Khandelwal
Deputy General Manager
Friday, June 2,2023 |